Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Parasitology Research|October 23, 2025
Factors associated with detecting pathogenic intestinal parasites in multiple stool microscopy samples: a retrospective cross-sectional studyThareerat Ananchaisarp, Wisarut Srisintorn, Pirun Saelue, et al.Value in Health Regional Issues|July 2, 2023
Real-World Costs and Cost-Effectiveness Analysis of Rabbit-Antithymocyte Globulin Versus Oxymetholone in Acquired Aplastic Anemia in ThailandThitichaya Penthinapong, Pirun Saelue, Warunsuda Sripakdee, et al.JCO Global Oncology|February 29, 2024
Trends in Anticoagulant Utilization and Clinical Outcomes for Cancer-Associated Thrombosis: A Multicenter Cohort Study in Thailand's Upper-Middle-Income Country SettingKirati Kengkla, Surakit Nathisuwan, Warunsuda Sripakdee, et al.Journal of Clinical Medicine|February 27, 2026
Long-Term Metabolic Remission and Predictive Factors After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in an Asian PopulationKanittha Sakolprakaikit, Kamthorn Yolsuriyanwong, Siripong Cheewatanakornkul, et al.Plos One|August 29, 2025
Exosomal miRNA expression profiling in patients with imatinib resistant Chronic myeloid leukemia: A pilot studyRaphatphorn Navakanitworakul, Pirun Saelue, Tipparat Penglong, et al.Clinical Lymphoma, Myeloma & Leukemia|September 18, 2022
Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study GroupChantiya Chanswangphuwana, Chantana Polprasert, Weerapat Owattanapanich, et al.Hematology (Amsterdam, Netherlands)|March 23, 2023
Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWGSmith Kungwankiattichai, Weerapat Owattanapanich, Thanawat Rattanathammethee, et al.Clinical Lymphoma, Myeloma & Leukemia|September 15, 2018
Improved Survival of Elderly-fit Patients With Acute Myeloid Leukemia Requiring Intensive Therapy: 3-Year Multicenter Analysis From TALWGWeerapat Owattanapanich, Eakkapol Utchariyaprasit, Adisak Tantiworawit, et al.Clinical Lymphoma, Myeloma & Leukemia|July 6, 2022
Comparison of Three Doses of Cytarabine Consolidation for Intermediate- and Adverse-risk Acute Myeloid Leukemia: Real World Evidence From Thai Acute Myeloid Leukemia RegistryChantiya Chanswangphuwana, Chantana Polprasert, Weerapat Owattanapanich, et al.Clinical Lymphoma, Myeloma & Leukemia|April 30, 2021
Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG)Chinadol Wanitpongpun, Eakkapol Utchariyaprasit, Weerapat Owattanapanich, et al.Pageof 3